Inventor · disambiguated record
Karl-Heinrich Fritzemeier
Also filed as: FRITZEMEIER KARL · FRITZEMEIER KARL-HEINRICH
32 granted patents·12 pending applications·386 citations·filing 1990–2009
97Inventor score
Top patents by PatentIndex Score
44 records- 0195US6958327B118 Norsteroids as selectively active estrogensSCHERING AG·Filed 2000·Granted Oct 25, 2005·88 cites·35 claims
- 0292US7414043B29-α-substituted estratrienes as selectively active estrogensSCHERING AG·Filed 2003·Granted Aug 19, 2008·56 cites·26 claims
- 0391US6344454B1Nonsteroidal gestagensSCHERING AG·Filed 2000·Granted Feb 5, 2002·29 cites·24 claims
- 0490US7378404B28β-hydrocarbyl-substituted estratrienes for use as selective estrogensSCHERING AG·Filed 2001·Granted May 27, 2008·52 cites·41 claims
- 0589US6548534B2Nonsteroidal gestagensSCHERING AG·Filed 2001·Granted Apr 15, 2003·20 cites·25 claims
- 0689US6245804B1Nonsteroidal gestagensSCHERING AG·Filed 1998·Granted Jun 12, 2001·34 cites·25 claims
- 0779US6844336B24-fluoroalkyl-2h-benzopyrans with anti-estogenic activitySCHERING AG·Filed 2001·Granted Jan 18, 2005·14 cites·36 claims
- 0873US6790842B111β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTSSCHERING AG·Filed 2000·Granted Sep 14, 2004·7 cites·15 claims
- 0969US7109360B116-hydroxyestratrienes as selectively active estrogensSCHERING AG·Filed 2000·Granted Sep 19, 2006·6 cites·13 claims
- 1069US7074829B2Antiestrogens, process for their production and their pharmaceutical useSCHERING AG·Filed 2003·Granted Jul 11, 2006·3 cites·16 claims
- 1161US6794409B2Use of ERβ-selective ligands for regulating fertility and compounds useful thereforSCHERING AG·Filed 2002·Granted Sep 21, 2004·1 cites·27 claims
- 1261US5232915A9α-hydroxy-19,11β-bridged steroids, their production and pharmaceutical preparations containing these steroidsSCHERING AG·Filed 1990·Granted Aug 3, 1993·14 cites·10 claims
- 1359US6670347B219-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ringSCHERING AG·Filed 2001·Granted Dec 30, 2003·2 cites·32 claims
- 1459US5478956A8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing themSCHERING AG·Filed 1991·Granted Dec 26, 1995·16 cites·20 claims
- 1556US2008132476A1Substituted estratrienes as selectively active estrogensKOSEMUND DIRK·Filed 2008·Application pending·0 cites
- 1655US6166075AAntiestrogens, process for their production and their pharmaceutical useSCHERING AG·Filed 1999·Granted Dec 26, 2000·10 cites·31 claims
- 1754US2008182829A18Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active EstrogensPETERS OLAF·Filed 2008·Application pending·0 cites
- 1853US2006270845A116-Hydroxyestratrienes as selectively active estrogensKUENZER HERMANN·Filed 2006·Application pending·0 cites
- 1951US2003203902A1Nonsteroidal gestagensSCHERING AG·Filed 2003·Application pending·0 cites
- 2050US2005020695A1Use of ERbeta-selective ligands for regulating fertility and compounds useful thereforFiled 2004·Application pending·0 cites
- 2149US5656622A15,15-dialkyl-substituted derivatives of estradiolSCHERING AG·Filed 1995·Granted Aug 12, 1997·7 cites·15 claims
- 2248US6780855B211β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTSSCHERING AG·Filed 1998·Granted Aug 24, 2004·8 cites·27 claims
- 2348US6559181B1Antiestrogens, process for their protection and their pharmaceutical useSCHERING AG·Filed 2000·Granted May 6, 2003·0 cites·16 claims
- 2448US2009099250A1Benzocycloheptene derivatives as estrogens having selective activityWYRWA RALF·Filed 2008·Application pending·0 cites
- 2547US5827842A14α, 17α-C2 -bridged norprogesterone derivativesSCHERING AG·Filed 1995·Granted Oct 27, 1998·6 cites·14 claims
- 2646US7119082B211β-long-chain-substituted 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ringSCHERING AG·Filed 2003·Granted Oct 10, 2006·0 cites·20 claims
- 2745US5236912AAntiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroidsSCHERING AG·Filed 1991·Granted Aug 17, 1993·5 cites·9 claims
- 2844US2011178052A19-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancerBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 2943US5523298AProgestationally active 19,11-bridged 4-estrenesSCHERING AG·Filed 1993·Granted Jun 4, 1996·4 cites·10 claims
- 3042US2009029957A18-beta-substituted estratrienes as selectively active estrogensPETERS OLAF·Filed 2008·Application pending·0 cites
- 3140US8445469B218-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latterBOHLMANN ROLF·Filed 2005·Granted May 21, 2013·0 cites·20 claims
- 3240US2005148560A1Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diolFiled 2004·Application pending·0 cites
- 3338US2005282791A118-nor steroids as selectively active estrogensHILLISCH ALEXANDER·Filed 2005·Application pending·0 cites
- 3438US2004053898A1Combination preparation with a erbeta selective estrogen and serm or antiestorgenFiled 2001·Application pending·0 cites
- 3535US5703066AProgestationally active 19,11-bridged 4-estrenesSCHERING AG·Filed 1995·Granted Dec 30, 1997·1 cites·13 claims
- 3635US2009029953A118-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latterBOHLMANN ROLF·Filed 2005·Application pending·0 cites
- 3734US6790843B1C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereofSCHERING AG·Filed 2000·Granted Sep 14, 2004·0 cites·6 claims
- 3831US6147065A14-α, 17-α-C2 bridged norprogesterone derivativesSCHERING AG·Filed 1999·Granted Nov 14, 2000·0 cites·30 claims
- 3930US6596713B1Steroid esters and amides, process for their production and their pharmaceutical useSCHERING AG·Filed 1997·Granted Jul 22, 2003·2 cites·21 claims
- 4030US6229029B111β-aryl substituted 14,17-ethanoestratriens, method for the production of these compounds and their use in the production of medicamentsSCHERING AG·Filed 1998·Granted May 8, 2001·1 cites·16 claims
- 4130US5389624AAntiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroidsSCHERING AG·Filed 1993·Granted Feb 14, 1995·0 cites·14 claims
- 4229US5491137A14α17α-(Propano-and 172 propeno) -estratrienesSCHERING AG·Filed 1992·Granted Feb 13, 1996·0 cites·6 claims
- 4329US5418227A14,16β-ethano-15β, 16(1)-cyclo-14β-estra-1,3,5(10)-trienesSCHERING AG·Filed 1992·Granted May 23, 1995·0 cites·4 claims
- 4425US5973172A14-α,17-α-C2 -bridged norprogesterone derivativesSCHERING AKITENGESELLSCHAFT·Filed 1998·Granted Oct 26, 1999·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Karl-Heinrich Fritzemeier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →